NVCR Q3 2020 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q3 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$133M+44.1% YoY

Gross Profit

$104M78.6% margin

Operating Income

$15M11.3% margin

Net Income

$9M7.0% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

+14.4%

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$28M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$431M

Total Liabilities

$124M

Stockholders' Equity

$307M

Cash & Equivalents

$234M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$133M	$92M	+44.1%
Gross Profit	$104M	$69M	+50.8%
Operating Income	$15M	$4M	+289.7%
Net Income	$9M	$2M	+381.0%

Geographic Segments

UNITED STATES

$93M70%

GERMANY

$23M17%

JAPAN

$8M6%

EMEA, Exculding Germany

$5M4%

CHINA

$4M3%